Skip to main content
OpenTrials

Clinical trial condition

HR+HER2- Advanced Breast Cancer

Explore clinical trials studying HR+HER2- Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

HR+HER2- Advanced Breast Cancer trial results

Active, Not Recruiting

A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation

NCT06625333

Conditions
HR+HER2- Advanced Breast Cancer
Locations
  • Novartis Investigative Site Arkhangelsk, Russia
  • Novartis Investigative Site Barnaul, Russia
  • Novartis Investigative Site Bryansk, Russia
  • Novartis Investigative Site Chelyabinsk, Russia
View all 20 locations
View Trial Details
Active, Not Recruiting

A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia

NCT06148506

Conditions
HR+HER2- Advanced Breast Cancer
Locations
  • Novartis Investigative Site Kaluga, Russia
  • Novartis Investigative Site Barnaul, Russia
  • Novartis Investigative Site Chelyabinsk, Russia
  • Novartis Investigative Site Irkutsk, Russia
View all 20 locations
View Trial Details